Orchid Pharma Limited has informed the Exchange regarding 'Boards comment on fine levied by Exchange'.
ORCHPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Orchid Pharma received a notice from NSE dated March 17, 2025, for non-compliance with Regulation 17(1A) of SEBI (LODR) Regulations, 2015, along with a fine. The company had already paid the fine and informed the exchange on March 31, 2025. The Board of Directors reviewed the matter in its meeting on May 26, 2025, took note of the exchange's communication, and resolved to avoid such non-compliance in the future. The filing is a formal board acknowledgment of the regulatory action and a commitment to compliance going forward.
This is a routine disclosure confirming that a regulatory fine has been paid and the board has acknowledged the lapse. For shareholders, this signals governance awareness but the financial impact is likely minimal since the fine has already been settled.